Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 16, 2022
[ Wed, Mar 16th 2022
] - WOPRAI
Tue, March 15, 2022
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
[ Tue, Mar 15th 2022
] - WOPRAI
Alexander Nowak Initiated (BVS) at Strong Buy and Held Target at $30 on, Mar 15th, 2022
Alexander Nowak of Craig-Hallum, Initiated "Bioventus Inc." (BVS) at Strong Buy and Held Target at $30 on, Mar 15th, 2022.
Alexander has made no other calls on BVS in the last 4 months.
There is 1 other peer that has a rating on BVS. Out of the 1 peers that are also analyzing BVS, 0 agree with Alexander's Rating of Hold.
This is the rating of the analyst that currently disagrees with Alexander
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Decreased Target to $18 on, Friday, March 11th, 2022
